Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Ischemic Heart Disease

  Free Subscription


Articles published in J Clin Endocrinol Metab

Retrieve available abstracts of 100 articles:
HTML format



Single Articles


    July 2021
  1. YU D, Wang Z, Zhang X, Qu B, et al
    Remnant cholesterol and cardiovascular mortality in patients with type 2 diabetes and incident diabetic nephropathy.
    J Clin Endocrinol Metab. 2021 Jul 22. pii: 6325383. doi: 10.1210.
    PubMed     Abstract available


  2. ROMERO DG, Yanes Cardozo LL
    Cardiovascular Events in Polycystic Ovary Syndrome: Is the Debate Settled for Good?
    J Clin Endocrinol Metab. 2021 Jul 10. pii: 6318749. doi: 10.1210.
    PubMed    


  3. ARIBAS E, Kavousi M, Laven JSE, Ikram MA, et al
    Aging, cardiovascular risk and SHBG levels in men and women from the general population.
    J Clin Endocrinol Metab. 2021 Jul 1. pii: 6312672. doi: 10.1210.
    PubMed     Abstract available


    June 2021
  4. BERNI TR, Morgan CL, Rees DA
    Women with Polycystic Ovary Syndrome have an increased risk of major cardiovascular events: a population study.
    J Clin Endocrinol Metab. 2021 Jun 1. pii: 6290890. doi: 10.1210.
    PubMed     Abstract available


    May 2021
  5. HOU W, Gao J, Jiang W, Wei W, et al
    Meal Timing of Subtypes of Macronutrients Consumption With Cardiovascular Diseases: NHANES, 2003 to 2016.
    J Clin Endocrinol Metab. 2021 May 26. pii: 6279652. doi: 10.1210.
    PubMed     Abstract available



  6. Corrigendum to: "Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline".
    J Clin Endocrinol Metab. 2021 May 8. pii: 6272552. doi: 10.1210.
    PubMed    


    April 2021
  7. SHAO S, Zhou K, Liu X, Liu L, et al
    Predictive value of serum lipid for intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease.
    J Clin Endocrinol Metab. 2021 Apr 10. pii: 6219846. doi: 10.1210.
    PubMed     Abstract available


    March 2021
  8. LANGDAHL BL, Hofbauer LC, Forfar JC
    Cardiovascular Safety and Sclerostin Inhibition - a mini-review.
    J Clin Endocrinol Metab. 2021 Mar 23. pii: 6182322. doi: 10.1210.
    PubMed     Abstract available


  9. BELLO-CHAVOLLA OY, Antonio-Villa NE, Fernandez-Chirino L, Vargas-Vazquez A, et al
    Letter to the Editor from Omar Yaxmehen Bello-Chavolla: "Are the Different Diabetes Subgroups Correlated With All-Cause, Cancer related, and Cardiovascular-related Mortality?"
    J Clin Endocrinol Metab. 2021 Mar 17. pii: 6174421. doi: 10.1210.
    PubMed    


  10. LI PF, Chen WL
    Response Letter to the Editor from Bello-Chavolla OY: "Are the Different Diabetes Subgroups Correlated With All-Cause, Cancer related, and Cardiovascular-related Mortality?"
    J Clin Endocrinol Metab. 2021 Mar 17. pii: 6174426. doi: 10.1210.
    PubMed    


  11. TORKY A, Sinaii N, Jha S, Desai J, et al
    Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia.
    J Clin Endocrinol Metab. 2021 Mar 2. pii: 6156969. doi: 10.1210.
    PubMed     Abstract available


  12. YEN CL, Fan PC, Lin MS, Lee CC, et al
    Fenofibrate Delays the Need for Dialysis and Reduces Cardiovascular Risk among Patients with Advanced CKD.
    J Clin Endocrinol Metab. 2021 Mar 2. pii: 6156972. doi: 10.1210.
    PubMed     Abstract available


    February 2021
  13. NGAOSUWAN K, Johnston DG, Godsland IF, Cox J, et al
    Cardiovascular disease in patients with primary and secondary adrenal insufficiency and the role of comorbidities.
    J Clin Endocrinol Metab. 2021 Feb 15. pii: 6135110. doi: 10.1210.
    PubMed     Abstract available


    January 2021
  14. SHUFELT CL, Manson JE
    Menopausal Hormone Therapy and Cardiovascular Disease: The Role of Formulation, Dose, and Route of Delivery.
    J Clin Endocrinol Metab. 2021 Jan 28. pii: 6121688. doi: 10.1210.
    PubMed     Abstract available


    November 2020
  15. KAHALI B, Chen Y, Feitosa MF, Bielak LF, et al
    A noncoding variant near PPP1R3B promotes liver glycogen storage and MetS, but protects against myocardial infarction.
    J Clin Endocrinol Metab. 2020 Nov 24. pii: 5999530. doi: 10.1210.
    PubMed     Abstract available


  16. LIU M, Zhang Z, Zhou C, He P, et al
    Relationship of weight change patterns from young to middle adulthood with incident cardiovascular diseases.
    J Clin Endocrinol Metab. 2020 Nov 12. pii: 5979521. doi: 10.1210.
    PubMed     Abstract available


    October 2020
  17. COUPER JJ, Jones TW, Chee M, Barrett HL, et al
    Determinants of cardiovascular risk in 7,000 youth with type 1 diabetes in the Australasian Diabetes Data Network.
    J Clin Endocrinol Metab. 2020 Oct 30. pii: 5943231. doi: 10.1210.
    PubMed     Abstract available


    September 2020
  18. LI PF, Chen WL
    Are the Different Diabetes Subgroups Correlated With All-Cause, Cancer-related, and Cardiovascular-related Mortality?
    J Clin Endocrinol Metab. 2020 Sep 7. pii: 5902292. doi: 10.1210.
    PubMed     Abstract available


  19. HJORTEBJERG R, Rasmussen LM, Gude MF, Irmukhamedov A, et al
    Local IGF bioactivity associates with high PAPP-A activity in the pericardial cavity of cardiovascular disease patients.
    J Clin Endocrinol Metab. 2020 Sep 1. pii: 5900391. doi: 10.1210.
    PubMed     Abstract available


    August 2020
  20. BRANDTNER EM, Muendlein A, Leiherer A, Armbruster FP, et al
    Serum Parathyroid Hormone Predicts Mortality in Coronary Angiography Patients with Type 2 Diabetes.
    J Clin Endocrinol Metab. 2020 Aug 12. pii: 5891791. doi: 10.1210.
    PubMed     Abstract available


  21. JIA X, Sun C, Tang O, Gorlov I, et al
    Plasma dehydroepiandrosterone sulfate and cardiovascular disease risk in older men and women.
    J Clin Endocrinol Metab. 2020 Aug 12. pii: 5891765. doi: 10.1210.
    PubMed     Abstract available


    July 2020
  22. RODRIGUEZ AJ, Ernst MT, Nybo M, Prieto-Alhambra D, et al
    Oral bisphosphonate use reduces cardiovascular events in a cohort of Danish patients referred for bone mineral density.
    J Clin Endocrinol Metab. 2020 Jul 27. pii: 5876920. doi: 10.1210.
    PubMed     Abstract available


  23. COSMAN F, Peterson LR, Towler DA, Mitlak B, et al
    Cardiovascular Safety of Abaloparatide in Postmenopausal Women with Osteoporosis: Analysis from the ACTIVE Phase 3 Trial.
    J Clin Endocrinol Metab. 2020 Jul 13. pii: 5870711. doi: 10.1210.
    PubMed     Abstract available


    June 2020
  24. SNAITH JR, Holmes-Walker DJ, Greenfield JR
    Letter to the Editor: Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry.
    J Clin Endocrinol Metab. 2020 Jun 17. pii: 5859155. doi: 10.1210.
    PubMed    


  25. ZHANG X, Jones KL, Horowitz M, Rayner CK, et al
    Effects of proximal and distal enteral glucose infusion on cardiovascular response in health and type 2 diabetes.
    J Clin Endocrinol Metab. 2020 Jun 4. pii: 5851469. doi: 10.1210.
    PubMed     Abstract available


  26. INZUCCHI SE, Khunti K, Fitchett DH, Wanner C, et al
    Cardiovascular (CV) Benefit of Empagliflozin Across the Spectrum of CV Risk Factor Control in the EMPA-REG OUTCOME Trial.
    J Clin Endocrinol Metab. 2020 Jun 2. pii: 5850548. doi: 10.1210.
    PubMed     Abstract available


    May 2020
  27. CHANG CY, Chien YJ, Lin PC, Chen CS, et al
    Non-thyroidal illness syndrome and hypothyroidism in ischemic heart disease population: Systematic review and meta-analysis.
    J Clin Endocrinol Metab. 2020 May 27. pii: 5847674. doi: 10.1210.
    PubMed     Abstract available


  28. KOZAKOVA M, Morizzo C, Penno G, Shore AC, et al
    Plasma Homocysteine and Cardiovascular Organ Damage in a Population with a High Prevalence of Risk Factors.
    J Clin Endocrinol Metab. 2020 May 26. pii: 5846189. doi: 10.1210.
    PubMed     Abstract available


  29. NG JCM, Schooling CM
    Effect of glucagon on ischemic heart disease and its risk factors: A Mendelian randomization study.
    J Clin Endocrinol Metab. 2020 May 14. pii: 5837127. doi: 10.1210.
    PubMed     Abstract available


  30. MAROULI E, Kus A, Del Greco M F, Chaker L, et al
    Thyroid function affects the risk of stroke via atrial fibrillation: a Mendelian Randomization study.
    J Clin Endocrinol Metab. 2020 May 6. pii: 5831244. doi: 10.1210.
    PubMed     Abstract available


    April 2020
  31. LEUNG JH, Bayomy OF, Bonyhay I, Celli J, et al
    ACTH Infusion Impairs Baroreflex Sensitivity-Implications for Cardiovascular Hypoglycemia-Associated Autonomic Failure.
    J Clin Endocrinol Metab. 2020 Apr 30. pii: 5827417. doi: 10.1210.
    PubMed     Abstract available


  32. DAVIS WA, Gregg EW, Davis TME
    Temporal trends in cardiovascular complications in people with or without type 2 diabetes: The Fremantle Diabetes Study.
    J Clin Endocrinol Metab. 2020 Apr 30. pii: 5825446. doi: 10.1210.
    PubMed     Abstract available


  33. CROYAL M, Saulnier PJ, Aguesse A, Gand E, et al
    Plasma Trimethylamine N-oxide and risk of cardiovascular events in patients with type 2 diabetes.
    J Clin Endocrinol Metab. 2020 Apr 17. pii: 5821201. doi: 10.1210.
    PubMed     Abstract available


  34. CALDER GL, Ward GM, Sachithanandan N, MacIsaac RJ, et al
    Insulin Autoimmune Syndrome: A Case of Clopidogrel-induced Autoimmune Hypoglycemia.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    March 2020
  35. KRISHNAVENI GV, Veena SR, Johnson M, Kumaran K, et al
    Maternal B12, folate and homocysteine concentrations and offspring cortisol and cardiovascular responses to stress.
    J Clin Endocrinol Metab. 2020 Mar 24. pii: 5811162. doi: 10.1210.
    PubMed     Abstract available


  36. WU VC, Chueh JS, Hsieh MY, Hu YH, et al
    Familial aggregation and heritability of primary Aldosteronism with Cardiovascular events: a population-based family cohort study.
    J Clin Endocrinol Metab. 2020 Mar 20. pii: 5810354. doi: 10.1210.
    PubMed     Abstract available


  37. VACCARO O, Nicolucci A, Lucisano G, Masulli M, et al
    Response to Letter to the Editor: "Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care".
    J Clin Endocrinol Metab. 2020;105.
    PubMed    


  38. DE CARVALHO LSF, Coelho OR, Sposito AC
    Letter to the Editor: "Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care".
    J Clin Endocrinol Metab. 2020;105.
    PubMed    


    February 2020
  39. CAO M, Cui B
    Negative Effects of Age at Menarche on Risk of Cardiometabolic Diseases in Adulthood: A Mendelian Randomization Study.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    January 2020
  40. SHAH VN, Bailey R, Wu M, Foster NC, et al
    Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry.
    J Clin Endocrinol Metab. 2020 Jan 19. pii: 5709622. doi: 10.1210.
    PubMed     Abstract available


  41. NEVES JS, Correa S, Baeta Baptista R, Bigotte Vieira M, et al
    Association of prediabetes with CKD progression and adverse cardiovascular outcomes: an analysis of the CRIC study.
    J Clin Endocrinol Metab. 2020 Jan 16. pii: 5707316. doi: 10.1210.
    PubMed     Abstract available



  42. CORRIGENDUM FOR "The Effect of Testosterone on Cardiovascular Biomarkers in the Testosterone Trials".
    J Clin Endocrinol Metab. 2020;105.
    PubMed    


    December 2019
  43. ZHOU Y, Huang Y, Ji X, Wang X, et al
    Pioglitazone for the primary and secondary prevention of cardiovascular and renal outcomes in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis.
    J Clin Endocrinol Metab. 2019 Dec 11. pii: 5673086. doi: 10.1210.
    PubMed     Abstract available


    November 2019
  44. SHAIKH K, Ellenberg SS, Nakanishi R, Snyder PJ, et al
    Biomarkers and Non-Calcified Coronary Artery Plaque Progression in Older Men Treated with Testosterone.
    J Clin Endocrinol Metab. 2019 Nov 30. pii: 5648063. doi: 10.1210.
    PubMed     Abstract available


  45. RAZVI S, Leng O, Jabbar A, Bano A, et al
    Sample Timing, diagnosis of Subclinical Thyroid Dysfunction and Mortality in Acute Myocardial Infarction: ThyrAMI1 study.
    J Clin Endocrinol Metab. 2019 Nov 26. pii: 5643808. doi: 10.1210.
    PubMed     Abstract available


  46. WU H, Xu L, Ballantyne CM
    sDietary and pharmacological fatty acids and cardiovascular health.
    J Clin Endocrinol Metab. 2019 Nov 2. pii: 5611200. doi: 10.1210.
    PubMed     Abstract available


    October 2019
  47. LEE AK, Woodward M, Wang D, Ohkuma T, et al
    The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE.
    J Clin Endocrinol Metab. 2019 Oct 7. pii: 5582233. doi: 10.1210.
    PubMed     Abstract available


    August 2019
  48. GYAWALI P, Martin SA, Heilbronn LK, Vincent AD, et al
    Higher serum sex hormone-binding globulin (SHBG) levels are associated with incident cardiovascular disease (CVD) in men.
    J Clin Endocrinol Metab. 2019 Aug 7. pii: 5544495. doi: 10.1210/jc.2019-01317.
    PubMed     Abstract available


  49. DI DALMAZI G, Fanelli F, Zavatta G, Ricci Bitti S, et al
    The steroid profile of adrenal incidentalomas: subtyping subjects with high cardiovascular risk.
    J Clin Endocrinol Metab. 2019 Aug 5. pii: 5542836. doi: 10.1210/jc.2019-00365.
    PubMed     Abstract available


    July 2019
  50. MELHUS H, Michaelsson K, Larsson SC
    Serum Parathyroid Hormone and Risk of Coronary Artery Disease: Exploring Causality using Mendelian Randomization.
    J Clin Endocrinol Metab. 2019 Jul 16. pii: 5532038. doi: 10.1210/jc.2019-01063.
    PubMed     Abstract available


    June 2019
  51. ALEKSANDROVA K, Drogan D, Weikert C, Schulze MB, et al
    Fatty Acid-Binding Protein 4 and Risk of Type 2 Diabetes, Myocardial Infarction and Stroke: A Prospective Cohort Study.
    J Clin Endocrinol Metab. 2019 Jun 18. pii: 5519297. doi: 10.1210/jc.2019-00477.
    PubMed     Abstract available


  52. POTT J, Bae YJ, Horn K, Teren A, et al
    Genetic association study of eight steroid hormones and implications for sexual dimorphism of coronary artery disease.
    J Clin Endocrinol Metab. 2019 Jun 6. pii: 5511541. doi: 10.1210/jc.2019-00757.
    PubMed     Abstract available


    May 2019
  53. VACCARO O, Lucisano G, Masulli M, Bonora E, et al
    Cardiovascular effects of pioglitazone or sulphonylureas according to pretreatment risk: moving towards personalized care.
    J Clin Endocrinol Metab. 2019 May 6. pii: 5485080. doi: 10.1210/jc.2019-00361.
    PubMed     Abstract available


  54. MURAD MH, Larrea-Mantilla L, Haddad A, Spencer-Bonilla G, et al
    Antihypertensive Agents in Older Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    J Clin Endocrinol Metab. 2019;104:1575-1584.
    PubMed     Abstract available


  55. PONCE OJ, Larrea-Mantilla L, Hemmingsen B, Serrano V, et al
    Lipid-Lowering Agents in Older Individuals: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    J Clin Endocrinol Metab. 2019;104:1585-1594.
    PubMed     Abstract available


    April 2019
  56. HARADA M, Fujihara K, Osawa T, Yamamoto M, et al
    Relationship between Number of Multiple Risk Factors and Coronary Artery Disease Risk With and Without Diabetes Mellitus.
    J Clin Endocrinol Metab. 2019 Apr 17. pii: 5469228. doi: 10.1210/jc.2019-00168.
    PubMed     Abstract available


  57. HIEMSTRA T, Lim K, Thadhani R, Manson JE, et al
    Vitamin D and Atherosclerotic Cardiovascular Disease.
    J Clin Endocrinol Metab. 2019 Apr 4. pii: 5426811. doi: 10.1210/jc.2019-00194.
    PubMed     Abstract available


  58. BANO A, Chaker L, de Maat MPM, Atiq F, et al
    Thyroid function and cardiovascular disease: the mediating role of coagulation factors.
    J Clin Endocrinol Metab. 2019 Apr 2. pii: 5423567. doi: 10.1210/jc.2019-00072.
    PubMed     Abstract available


    March 2019
  59. MORENO RC, Navas-Acien A, Escolar E, Nathan DM, et al
    Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes.
    J Clin Endocrinol Metab. 2019 Mar 14. pii: 5376633. doi: 10.1210/jc.2018-01484.
    PubMed     Abstract available


  60. EJLSMARK-SVENSSON H, Rolighed L, Rejnmark L
    Effect of Parathyroidectomy on cardiovascular risk factors in primary hyperparathyroidism: A randomised clinical trial.
    J Clin Endocrinol Metab. 2019 Mar 12. pii: 5372733. doi: 10.1210/jc.2018-02456.
    PubMed     Abstract available


    February 2019
  61. NATTERO-CHAVEZ L, Redondo Lopez S, Alonso Diaz S, Garnica Urena M, et al
    Association of cardiovascular autonomic dysfunction with peripheral arterial stiffness in patients with type 1 diabetes.
    J Clin Endocrinol Metab. 2019 Feb 20. pii: 5342945. doi: 10.1210/jc.2018-02729.
    PubMed     Abstract available


  62. HUANG RC, Lillycrop KA, Beilin LJ, Godfrey KM, et al
    Epigenetic age acceleration in adolescence associates with BMI, inflammation and risk score for middle age cardiovascular disease.
    J Clin Endocrinol Metab. 2019 Feb 20. pii: 5342941. doi: 10.1210/jc.2018-02076.
    PubMed     Abstract available


  63. SCHADE DS, Eaton RP
    A Simplified Approach to Reducing Cardiovascular Risk.
    J Clin Endocrinol Metab. 2019 Feb 20. pii: 5342943. doi: 10.1210/jc.2018-02509.
    PubMed     Abstract available


  64. BEHESHTI S, Madsen CM, Varbo A, Nordestgaard BG, et al
    How to identify familial premature myocardial infarction: comparing approaches to identify familial hypercholesterolemia.
    J Clin Endocrinol Metab. 2019 Feb 7. pii: 5307688. doi: 10.1210/jc.2018-02261.
    PubMed     Abstract available


  65. JUONALA M, Pitkanen N, Tolonen S, Laaksonen M, et al
    Childhood exposure to passive smoking and bone health in adulthood. The Cardiovascular Risk in Young Finns Study.
    J Clin Endocrinol Metab. 2019 Feb 1. pii: 5304739. doi: 10.1210/jc.2018-02501.
    PubMed     Abstract available


    January 2019
  66. SKOV J, Sundstrom A, Ludvigsson JF, Kampe O, et al
    Sex-specific risk of cardiovascular disease in autoimmune Addison's disease - a population-based cohort study.
    J Clin Endocrinol Metab. 2019 Jan 3. pii: 5270381. doi: 10.1210/jc.2018-02298.
    PubMed     Abstract available


    November 2018
  67. OH TJ, Moon JH, Choi SH, Lim S, et al
    Body-weight fluctuation and incident diabetes mellitus, cardiovascular disease, and mortality: a 16-year prospective cohort study.
    J Clin Endocrinol Metab. 2018 Nov 29. pii: 5214055. doi: 10.1210/jc.2018-01239.
    PubMed     Abstract available


  68. GUASCH-FERRE M, Ruiz-Canela M, Li J, Zheng Y, et al
    Plasma acylcarnitines and risk of type 2 diabetes in a Mediterranean population at high cardiovascular risk.
    J Clin Endocrinol Metab. 2018 Nov 13. pii: 5172268. doi: 10.1210/jc.2018-01000.
    PubMed     Abstract available


    September 2018
  69. TAMHANE S, Rodriguez-Gutierrez R, Iqbal AM, Prokop L, et al
    Cardiovascular and Metabolic Outcomes in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2018 Sep 28. pii: 5107761. doi: 10.1210/jc.2018-01862.
    PubMed     Abstract available


  70. AL-SOFIANI ME, Yanek LR, Faraday N, Kral BG, et al
    Diabetes and Platelet Response to Low-dose Aspirin.
    J Clin Endocrinol Metab. 2018 Sep 27. pii: 5107300. doi: 10.1210/jc.2018-01254.
    PubMed     Abstract available


  71. RITCHEY ME, Harding A, Hunter S, Peterson C, et al
    Cardiovascular Safety During and After Use of Phentermine and Topiramate.
    J Clin Endocrinol Metab. 2018 Sep 21. pii: 5104461. doi: 10.1210/jc.2018-01010.
    PubMed     Abstract available


    August 2018
  72. STRAND E, Rebnord EW, Pedersen ER
    Response to letter to the Editor: Serum Carnitine Metabolites and Incident Type 2 Diabetes Mellitus in Patients with Suspected Stable Angina Pectoris.
    J Clin Endocrinol Metab. 2018 Aug 14. pii: 5073239. doi: 10.1210/jc.2018-01647.
    PubMed    


  73. LIEPINSH E, Dambrova M
    Letter to the Editor: Serum Carnitine Metabolites and Incident Type 2 Diabetes Mellitus in Patients with Suspected Stable Angina Pectoris.
    J Clin Endocrinol Metab. 2018 Aug 14. pii: 5073236. doi: 10.1210/jc.2018-01408.
    PubMed    


  74. EMANUELSSON F, Nordestgaard BG, Benn M
    Familial hypercholesterolemia and risk of peripheral arterial disease and chronic kidney disease.
    J Clin Endocrinol Metab. 2018 Aug 3. pii: 5063925. doi: 10.1210/jc.2018-01058.
    PubMed     Abstract available


  75. HSU PF, Sung SH, Cheng HM, Shin SJ, et al
    Cardiovascular benefits of acarbose versus sulfonylureas in type 2 diabetic patients treated with metformin.
    J Clin Endocrinol Metab. 2018 Aug 2. pii: 5063484. doi: 10.1210/jc.2018-00040.
    PubMed     Abstract available


    July 2018
  76. LYU Y, Luo Y, Li C, Guo X, et al
    Regional differences in the prevalence of coronary heart disease and stroke in patients with type 2 diabetes in China.
    J Clin Endocrinol Metab. 2018 Jul 3. pii: 5047769. doi: 10.1210/jc.2018-00422.
    PubMed     Abstract available


    May 2018
  77. NICHOLS GA, Philip S, Reynolds K, Granowitz CB, et al
    Increased Cardiovascular Risk in Hypertriglyceridemic Patients with Statin-Controlled LDL Cholesterol.
    J Clin Endocrinol Metab. 2018 May 29. pii: 5005949. doi: 10.1210/jc.2018-00470.
    PubMed     Abstract available


  78. PARK J, Blackburn BE, Ganz PA, Rowe K, et al
    Risk Factors for Cardiovascular Disease among Thyroid Cancer Survivors: Findings from the Utah Cancer Survivors Study.
    J Clin Endocrinol Metab. 2018 May 29. pii: 5005948. doi: 10.1210/jc.2017-02629.
    PubMed     Abstract available


  79. THURSTON RC, Bhasin S, Chang Y, Barinas Mitchell E, et al
    Reproductive Hormones and Subclinical Cardiovascular Disease in Midlife Women.
    J Clin Endocrinol Metab. 2018 May 18. pii: 4999000. doi: 10.1210/jc.2018-00579.
    PubMed     Abstract available


  80. OTTOSSON F, Smith E, Melander O, Fernandez C, et al
    Altered asparagine and glutamate homeostasis precede coronary artery disease and type-2 diabetes.
    J Clin Endocrinol Metab. 2018 May 16. pii: 4996516. doi: 10.1210/jc.2018-00546.
    PubMed     Abstract available


    April 2018
  81. STAHLI BE, Nozza A, Schrieks IC, Buse JB, et al
    Homeostasis Model Assessment of Insulin Resistance and Survival in Patients with Diabetes and Acute Coronary Syndrome.
    J Clin Endocrinol Metab. 2018 Apr 6. pii: 4963641. doi: 10.1210/jc.2017-02772.
    PubMed     Abstract available


    March 2018
  82. FAWAD A, Bergmann A, Struck J, Nilsson PM, et al
    Proneurotensin predicts cardiovascular disease in an elderly population.
    J Clin Endocrinol Metab. 2018 Mar 13. pii: 4931667. doi: 10.1210/jc.2017-02424.
    PubMed     Abstract available


  83. KIM C, Aroda VR, Goldberg RB, Younes N, et al
    Response to Letter: Androgens, irregular menses, and risk of diabetes and coronary artery calcification in the Diabetes Prevention Program.
    J Clin Endocrinol Metab. 2018 Mar 12. pii: 4931069. doi: 10.1210/jc.2018-00244.
    PubMed    


  84. PASCHOU SA, Anagnostis P, Goulis DG, Siasos G, et al
    Letter to the Editor: Androgens, irregular menses, and risk of diabetes and coronary artery calcification in the Diabetes Prevention Program.
    J Clin Endocrinol Metab. 2018 Mar 12. pii: 4931067. doi: 10.1210/jc.2018-00018.
    PubMed    


    February 2018
  85. MEUN C, Franco OH, Dhana K, Jaspers L, et al
    High androgens in postmenopausal women and the risk for atherosclerosis and cardiovascular disease: the Rotterdam Study.
    J Clin Endocrinol Metab. 2018 Feb 1. pii: 4834041. doi: 10.1210/jc.2017-02421.
    PubMed     Abstract available


    January 2018
  86. WU CJ, Kao TW, Chang YW, Peng TC, et al
    Does the additional component of calf-circumference refine metabolic syndrome in Correlating with Cardiovascular Risk?
    J Clin Endocrinol Metab. 2018 Jan 15. pii: 4802111. doi: 10.1210/jc.2017-02320.
    PubMed     Abstract available


  87. DEGERUD E, Nygard O, de Vogel S, Hoff R, et al
    Plasma 25-hydroxyvitamin D and mortality in patients with suspected stable angina pectoris.
    J Clin Endocrinol Metab. 2018 Jan 9. pii: 4794886. doi: 10.1210/jc.2017-02328.
    PubMed     Abstract available


  88. STRAND E, Rebnord EW, Flygel MR, Lysne V, et al
    Serum Carnitine Metabolites and Incident Type 2 Diabetes Mellitus in Patients with Suspected Stable Angina Pectoris.
    J Clin Endocrinol Metab. 2018 Jan 9. pii: 4794884. doi: 10.1210/jc.2017-02139.
    PubMed     Abstract available


  89. YU D, Cai Y, Graffy J, Holman D, et al
    Development and external validation of risk scores for cardiovascular hospitalisation and rehospitalisation in diabetes patients.
    J Clin Endocrinol Metab. 2018 Jan 8. pii: 4792932. doi: 10.1210/jc.2017-02293.
    PubMed     Abstract available


    December 2017
  90. KIM C, Aroda VR, Goldberg RB, Younes N, et al
    Androgens, irregular menses, and risk of diabetes and coronary artery calcification in the Diabetes Prevention Program.
    J Clin Endocrinol Metab. 2017 Dec 6. pii: 4693937. doi: 10.1210/jc.2017-01829.
    PubMed     Abstract available


    October 2017
  91. TROISI R, Titus L, Hatch EE, Palmer JR, et al
    A Prospective Cohort Study of Prenatal Diethylstilbestrol Exposure and Cardiovascular Disease Risk.
    J Clin Endocrinol Metab. 2017 Oct 20. doi: 10.1210/jc.2017-01940.
    PubMed     Abstract available


  92. ANEKE-NASH CS, Xue X, Qi Q, Biggs ML, et al
    The Association between IGF-I and IGFBP-3 and Incident Diabetes in an Older Population of Men and Women in the Cardiovascular Health Study.
    J Clin Endocrinol Metab. 2017 Oct 12. doi: 10.1210/jc.2017-01273.
    PubMed     Abstract available


    September 2017
  93. RHEE EJ, Cho JH, Kwon H, Park SE, et al
    Association Between Coronary Artery Calcification and the Hemoglobin Glycation Index: The Kangbuk Samsung Health Study.
    J Clin Endocrinol Metab. 2017 Sep 27. doi: 10.1210/jc.2017-01723.
    PubMed     Abstract available


  94. PLAT J, Vreugdenhil ACE
    Response to Letter: Association of TSH With Cardiovascular Disease Risk in Overweight and Obese Children During Lifestyle Intervention.
    J Clin Endocrinol Metab. 2017 Sep 18. doi: 10.1210/jc.2017-01894.
    PubMed    


  95. RADETTI G, Longhi S, Sartorio A, Grugni G, et al
    Letter to the Editor: Association of TSH With Cardiovascular Disease Risk in Overweight and Obese Children During Lifestyle Intervention.
    J Clin Endocrinol Metab. 2017 Sep 18. doi: 10.1210/jc.2017-01505.
    PubMed    


  96. BERGTHORSDOTTIR R, Ragnarsson O, Skrtic S, Glad CAM, et al
    Visceral Fat and Novel Biomarkers of Cardiovascular Disease in Patients with Addison's Disease; a case-control study.
    J Clin Endocrinol Metab. 2017 Sep 13. doi: 10.1210/jc.2017-01324.
    PubMed     Abstract available


  97. MARAKA S, Singh Ospina N, Rodriguez-Gutierrez R, Davidge-Pitts CJ, et al
    Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis.
    J Clin Endocrinol Metab. 2017 Sep 13. doi: 10.1210/jc.2017-01643.
    PubMed     Abstract available


  98. KANG YM, Cho YK, Lee SE, Park JY, et al
    Cardiovascular Diseases and Life Expectancy in Adults With Type 2 Diabetes: A Korean National Sample Cohort Study.
    J Clin Endocrinol Metab. 2017;102:3443-3451.
    PubMed     Abstract available


    August 2017
  99. MONGRAW-CHAFFIN ML, Allison MA, Burke GL, Criqui MH, et al
    CT derived body fat distribution and incident cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis.
    J Clin Endocrinol Metab. 2017 Aug 16. doi: 10.1210/jc.2017-01113.
    PubMed     Abstract available


    February 2017
  100. TOULIS KA, Willis BH, Marshall T, Kumarendran B, et al
    All-cause mortality in patients with diabetes under treatment with dapagliflozin: a population-based, open-cohort study in THIN database.
    J Clin Endocrinol Metab. 2017 Feb 20. doi: 10.1210/jc.2016-3446.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: